Pioneer™ Select is a custom antibody generation service that delivers high-specificity recombinant antibodies using advanced phage display technology and rapid screening workflows.
Built on a 220‑billion‑sequence library and Bio‑Rad’s proprietary SpyDisplay selection technology, Pioneer Select enables rapid turnaround and flexible engagement models. Each antibody is precisely formatted and labeled via TrailBlazer™ technology to support PK and ADA assays, diagnostic immunoassays, basic research, and QC release testing in Fab, IgG, and additional formats.
Pioneer Select is a platform for custom recombinant antibody generation that uses phage display and high-throughput screening to produce tool antibodies tailored to specific antigen and application requirements.
Researchers choose Pioneer Select for its rapid 7‑week delivery, access to a 220‑billion‑sequence phage display library, guided selection strategies, recombinant antibody reproducibility, and flexible antibody formatting options.
|
|
|---|---|
|
Move projects forward faster |
Streamlined workflows deliver validated antibodies within 7 weeks |
|
Generate antibodies against challenging targets |
The 220-billion-sequence Pioneer library supports a wide range of antigen types |
|
Achieve specific binding characteristics |
Guided selection strategies can favour or exclude defined binding behaviours |
|
Support demanding bioanalytical assays |
Antibodies can be generated for PK, ADA, in vitro diagnostics, research, and QC applications |
|
Ensure reagent consistency |
Recombinant antibody generation provides reproducible, renewable reagents |
|
|
|
|
Anti-Idiotypic Antibodies Generating antibodies specific to free drug, total drug, and drug–target complexes enables the development of robust PK and ADA assays. |
Anti-Membrane Protein Antibodies Panning against membrane proteins in their native conformation using nanoparticles or overexpression cell lines is enabled. |
pH-Sensitive Antibodies Screening conditions can be tailored to selectively identify antibodies with binding or release properties at defined pH ranges. |
|
|
|
|
Anti-Peptide Antibodies Proven success with challenging peptides (e.g., GLP-1) strengthens our capability to deliver high-quality anti-peptide antibodies. |
Anti-Enzyme Antibodies Isolating antibodies that block enzymatic active sites supports inhibition studies and structural or functional characterization. |
Anti-Protein-Complex Antibodies Selective isolation of antibodies recognizing protein–protein complexes supports mechanistic studies. |
|
|
|---|---|
|
Pioneer library and SpyDisplay technology |
Enables high-affinity antibody selection to support demanding assays. Guided selection enables desired cross-reactivity while avoiding undesirable ones |
|
Diverse antigen compatibility |
Supports targets including but not limited to recombinant proteins, antibodies, cells, haptens, peptides, oligonucleotides, toxins, and inactivated viral or bacterial targets. |
|
Streamlined and automated workflow |
Delivers validated antibodies within just 7 weeks, minimizing re-work, accelerating timelines, and keeping your project reliably on schedule |
|
Flexible engagement |
Provides research use, optional therapeutic licensing, and deployment across in vitro diagnostics* and clinical monitoring applications |
*An agreement or indemnity letter may be required in some cases.
Pioneer Select employs tailored panning strategies that steer the selection toward your exact binding requirements.
Requirement: Antibodies binding the antigen but not a closely related antigen (CRA).
Strategy: Selection on antigen with library subtraction using the CRA to deplete unwanted cross-reactive binders.
Requirement: Antibodies recognizing epitopes present on two or three antigens (e.g., human and mouse target).
Strategy: Alternating selection rounds on two or three closely related antigens during panning.
Requirement: Two antibodies binding distinct, non-overlapping epitopes for sandwich assay formats.
Strategy: Epitope binning to identify binders to distinctive epitopes.
Requirement: Antibodies suitable under specific conditions, e.g., organic solvents or matrix components.
Strategy: Performing antibody selection directly under the target assay conditions to select functionally compatible binders.
Pioneer Select is a Bio-Rad custom bioanalytical antibody generation service that uses the pooled Pioneer phage display library in a streamlined panning strategy. It is specifically designed to deliver high‑affinity, assay‑ready antibodies for PK, ADA, research, clinical monitoring, and IVD applications.
Pioneer Select projects are completed within 7 weeks, providing validated antibodies prepared for subsequent applications. However, you should anticipate approximately 3 weeks of lead time.
We have the Pioneer Antibody Discovery Platform, specifically designed for discovering developable, diverse, and high-affinity biotherapeutic antibody candidates against challenging targets.
|
Campus Neuried, Anna-Sigmund-Str. 5 |
+49 89 809095-10 |